Chronic wound management remains a significant clinical challenge due to persistent infections and delayed tissue regeneration. In this study, the development and the evaluation of polyhydroxyalkanoate-coated magnetic nanoparticles (PHA-MNPs) derived from the cyanobacterium Desmonostoc muscorum as a novel topical agent for wound healing. PHA was extracted from D. muscorum biomass at a yield of 0.56 ± 0.03 g per g dry cell weight and used to coat magnetite nanoparticles synthesized via co-precipitation. The resulting PHA-MNPs were characterized by TEM (mean diameter 18 ± 3 nm), DLS (zeta potential − 25 ± 2 mV), FTIR, GC-MS, and UV–Vis spectroscopy. Antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa was quantified by broth microdilution assays (MICs comparable to ampicillin). Antibiofilm efficacy was assessed in microtiter plate assays, and hemocompatibility by hemolysis testing (< 5% hemolysis at ≤ 200 µg/mL). Cytotoxicity toward human epidermoid carcinoma (A431) and skin fibroblast (HFB4) cells was determined by MTT assays. In vivo wound healing was evaluated in a Wistar rat excisional wound model. Animals received topical low-dose PHA-MNPs (50 mg/kg), high-dose PHA-MNPs (100 mg/kg), Iruxol® (positive control), or no treatment for 16 days. Wound closure was measured photographically, and tissue samples underwent histopathological analysis. PHA-MNPs exhibited potent antibacterial and antibiofilm activities, selective cytotoxicity (IC₅₀ 45 µg/mL for A431 vs. >200 µg/mL for HFB4), and excellent hemocompatibility. Low-dose PHA-MNP treatment achieved 85 ± 5% wound closure, comparable to Iruxol® (95 ± 3%) and superior to the high-dose group (60 ± 6%) and untreated controls. Histology confirmed complete epithelialization and robust collagen deposition in low-dose and Iruxol® groups. PHA-MNPs produced from D. muscorum combine antimicrobial, antibiofilm, and regenerative properties with biocompatibility, representing a promising, sustainable nanobiomaterial for advanced wound care applications.
扫码关注我们
求助内容:
应助结果提醒方式:
